Vista Partners Publishes December 2012 Newsletter

Vista Partners Publishes December 2012 Newsletter 
Topics Include: Fiscal Cliff, Monthly Macroeconomic Commentary,
Investment Ideas & More 
SAN FRANCISCO, CA -- (Marketwire) -- 12/04/12 --  Vista Partners
("Vista") announced today that it published its FREE
macroeconomic/small cap oriented monthly newsletter for the month of
December. Each monthly newsletter from Vista contains macroeconomic
thoughts from Principal Analyst, Ross Silver, and monthly highlights
of each covered small cap company.  
Ross Silver, Principal Analyst at Vista Partners, states in the
newsletter, "For those of you unfamiliar with the 'Fiscal Cliff,'
simply put it is a combination of tax cuts, tax breaks and spending
cuts that will have a significant impact on the U.S. economic
recovery, if it is not handled appropriately. Over 1,000 government
programs, including the defense budget and Medicare, are in line for
deep, automatic cuts that begin in January 2013. Should nothing
happen, just about every economic expert alive believes we will go
into a recession, unemployment will sky rocket and the stock market
will head significantly lower."  
Mr. Silver also highlights in the newsletter, "ADVENTRX
Pharmaceuticals, Inc. (NYSE MKT: ANX) continues to focus its
resources on ANX-188 and the planned Phase 3 trial in sickle cell
disease scheduled to commence by the end of 2012. Should the trial
start within the next 27 days, we believe it may serve as a
considerable catalyst to the share price as evidenced by a number of
other biotech companies which have seen increases in their share
price due to the anticipation of near term catalysts such as Celsion
(ticker: CLSN)."  
To read more, please download the FREE December Newsletter available
at http://www.vistapglobal.com and click the "download newsletter"
icon.  
The Companies featured in the FREE December Newsletter are: Acorn
Energy, Inc. (NASDAQ: ACFN), ADVENTRX Pharmaceuticals, Inc. (NYSE
MKT: ANX), Algae.Tec Limited, Auxilio Inc., Oculus Innovative
Sciences, Inc. (NASDAQ: OCLS), Ohr Pharmaceutical, Inc. (OTCQB:
OHRP), and PositiveID Corporation. Other companies mentioned are
Roche, Novartis, Selexys, Regeneron, Pfizer, Lufthansa and others. 
To download the FREE December Newsletter, please visit
http://www.vistapglobal.com and click "Download Research &
Newsletter" or CLICK HERE to gain access.  
About Vista Partners:
 Vista Partners LLC, founded in 2005, is a
Registered Investment Advisor in the States of California and Oregon.
The firm's professional staff has backgrounds in finance, corporate
communications and investment banking.  
Please follow us on Twitter @VistaPResearch & Facebook at
Vista-Partners to receive updates, thoughts and ideas about and our
coverage universe of companies and more. 
Disclaimer & Disclosure:
 We encourage readers to view a complete
list of disclaimers and disclosures on our website:
www.vistapglobal.com.  
Contact:
Vista Partners LLC
877.215.4813 
info@vistapglobal.com 
 
 
Press spacebar to pause and continue. Press esc to stop.